CAJ | 학술논문

目的：探讨采用DC-CIK联合化疗加靶向治疗对于晚期结肠癌的临床治疗价值。方法随机选取2012年7月～2014年12月我院收治的晚期结肠癌患者60例，按照治疗方法的不同将其分为观察组和对照组，观察组行DC-CIK联合化疗加靶向治疗，对照组行化疗加靶向治疗，对两组患者的临床治疗效果进行回顾性分析。结果观察组的肿瘤控制率、毒副反应发生率均优于对照组，P＜0.05，差异具有统计学意义。结论采用DC-CIK联合化疗加靶向治疗对晚期结肠癌患者进行治疗，能够有效增强治疗方案对于肿瘤细胞的杀伤力，是一种可靠的治疗方法。
목적：탐토채용DC-CIK연합화료가파향치료대우만기결장암적림상치료개치。방법수궤선취2012년7월～2014년12월아원수치적만기결장암환자60례，안조치료방법적불동장기분위관찰조화대조조，관찰조행DC-CIK연합화료가파향치료，대조조행화료가파향치료，대량조환자적림상치료효과진행회고성분석。결과관찰조적종류공제솔、독부반응발생솔균우우대조조，P＜0.05，차이구유통계학의의。결론채용DC-CIK연합화료가파향치료대만기결장암환자진행치료，능구유효증강치료방안대우종류세포적살상력，시일충가고적치료방법。
Objective To evaluate the use of DC-CIK combined with chemotherapy plus targeted therapy for advanced colorectal cancer clinical therapeutic value.Methods Randomly selected 60 patients with advanced colon cancer from July 2012 to December 2014 in our hospital, according to the different treatment methods were divided into the control group and the observation group, the observation group adopt line combination chemotherapy plus DC-CIK targeted therapy, the control group underwent chemotherapy plus targeted therapy for clinical treatment, of two groups of patients were analyzed retrospectively.Results The tumor control rate was observed in patients, the incidence of side effects was better than the control group,P<0.05, had difference statistically significance.ConclusionDC-CIK combined with chemotherapy plus targeted therapy for patients with advanced colorectal cancer treatment, can effectively enhance the treatment options for tumor cell destruction, it is a reliable method of treatment.